BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Sep 30, 15:43Prev. Close
11.50
Open Price
11.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.59 (427)
Profit & Loss account of Vaishali Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 97.88 | 81.76 | 63.82 | 75.82 | 52.31 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 97.88 | 81.76 | 63.82 | 75.82 | 52.31 | |
Total Operating Revenues | 99.03 | 86.28 | 69.66 | 75.82 | 53.77 | |
Other Income | 3.21 | 2.03 | 2.23 | 1.79 | 1.81 | |
Total Revenue | 102.23 | 88.31 | 71.89 | 77.61 | 55.58 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 90.10 | 71.75 | 57.10 | 63.54 | 45.86 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -4.43 | 2.67 | -2.42 | -0.04 | 0.29 | |
Employee Benefit Expenses | 2.58 | 2.32 | 2.08 | 2.10 | 1.85 | |
Finance Costs | 1.58 | 1.74 | 2.01 | 2.46 | 2.61 | |
Depreciation And Amortisation Expenses | 0.49 | 0.51 | 0.50 | 0.46 | 0.43 | |
Other Expenses | 10.68 | 8.40 | 3.77 | 3.37 | 3.14 | |
Total Expenses | 101.01 | 87.39 | 63.05 | 71.88 | 54.18 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.23 | 0.93 | 8.85 | 5.73 | 1.40 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 1.23 | 0.93 | 8.85 | 5.73 | 1.40 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.41 | 0.25 | 2.16 | 1.45 | 0.38 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.04 | 0.00 | -0.02 | -0.02 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.08 | 0.27 | 0.00 | |
Total Tax Expenses | 0.41 | 0.21 | 2.24 | 1.70 | 0.36 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 0.82 | 0.72 | 6.60 | 4.02 | 1.05 | |
Profit/Loss From Continuing Operations | 0.82 | 0.72 | 6.60 | 4.02 | 1.05 | |
Profit/Loss For The Period | 0.82 | 0.72 | 6.60 | 4.02 | 1.05 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 0.31 | 0.68 | 6.26 | 3.82 | 0.99 | |
Diluted EPS (Rs.) | 0.31 | 0.64 | 5.91 | 3.82 | 0.99 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y